Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Nobuharu Ohshima"'
Autor:
Maho Suzukawa, Ken Ohta, Masahiro Sugimoto, Nobuharu Ohshima, Nobuyuki Kobayashi, Hiroyuki Tashimo, Yasushi Tanimoto, Junko Itano, Goro Kimura, Shohei Takata, Takako Nakano, Takafumi Yamashita, Satoshi Ikegame, Kentaro Hyodo, Masahiro Abe, Kenji Chibana, Yosuke Kamide, Kazunori Sasaki, Hiroya Hashimoto
Publikováno v:
Allergology International, Vol 73, Iss 4, Pp 524-531 (2024)
Background: Asthma is characterized by phenotypes of different clinical, demographic, and pathological characteristics. Identifying the profile of exhaled volatile organic compounds (VOCs) in asthma phenotypes may facilitate establishing biomarkers a
Externí odkaz:
https://doaj.org/article/2057d213db6a49209f9b5a519faa0467
Autor:
Kazufumi Takada, MD, Maho Suzukawa, MD, PhD, Hiroyuki Tashimo, MD, PhD, Nobuharu Ohshima, MD, PhD, Yuma Fukutomi, MD, PhD, Nobuyuki Kobayashi, MD, Masami Taniguchi, MD, PhD, Masaki Ishii, MD, PhD, Masahiro Akishita, MD, PhD, Ken Ohta, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 11, Pp 100840- (2023)
Background: Asthma and chronic obstructive pulmonary disease (COPD) overlap (ACO) is characterized by concurrent features of asthma and COPD. Since disease pathogenesis, severities, and treatments differ between asthma and ACO, it is important to dif
Externí odkaz:
https://doaj.org/article/618922f260144bf5b27f30d0c50a0e21
Autor:
Koichi Kobayashi, Taisuke Jo, Wataru Mimura, Maho Suzukawa, Nobuharu Ohshima, Goh Tanaka, Manabu Akazawa, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga, Takahide Nagase, Hideaki Nagai
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 8, Pp 2661-2669 (2021)
A national routine pneumococcal pneumonia immunization program started in Japan in 2014. It targeted the population aged ≥65 years and used a 23-valent pneumococcal polysaccharide vaccine; PPSV23. However, its effectiveness was not well defined bec
Externí odkaz:
https://doaj.org/article/e83a9e6e5d904936bd1c43baf7f4ea16
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 9, Pp 2285-2291 (2020)
An observational study to assess immunogenicity before and after the first, second, and third vaccinations with the 23-valent pneumococcal polysaccharide vaccine in a cohort of 16 elderly patients with chronic lung diseases was conducted. The safety
Externí odkaz:
https://doaj.org/article/1ac70c1d57284427a0cf8e83848555ed
Autor:
Takafumi Kato, Shinobu Akagawa, Kei Kusaka, Masahiro Kawashima, Nobuharu Ohshima, Masashi Kitani, Akira Hebisawa, Hirotoshi Matsui
Publikováno v:
Respiratory Medicine Case Reports, Vol 32, Iss , Pp 101332- (2021)
Yellow nail syndrome (YNS) is a rare entity characterized by thickened yellowish nails, lymphedema and respiratory manifestations such as pleural effusion. Lymphatic dysfunction is considered as a cause of YNS. However, evidence of systemic dilatatio
Externí odkaz:
https://doaj.org/article/08d3876aa89f4d3da8fd3bee040f207b
Autor:
Takafumi Kato, Koichi Kobayashi, Maho Suzukawa, Minako Saito, Kenichi Okuda, Kazuya Koyama, Sayaka Igarashi, Sayaka Arakawa, Nobuharu Ohshima, Hirotoshi Matsui, Takahide Nagase, Ken Ohta
Publikováno v:
Allergology International, Vol 66, Iss S, Pp S56-S58 (2017)
Externí odkaz:
https://doaj.org/article/317b8615aadc40349aa0cdf0c251a612
Autor:
Nobuharu Ohshima, Hirotoshi Matsui, Yoshinori Matsui, Masahiro Kawashima, Masahiro Shimada, Naoko Higaki, Shunsuke Shoji, Hiroo Wada, Akira Fujita, Hidehiro Watanabe, Norio Yamaguchi, Rokuro Matsuoka, Kazuhiko Oki, Hisaho Takahashi, Michiaki Suzuki, Hiroomi Yamazaki, Masafumi Yoshizawa, Hajime Goto
Publikováno v:
Allergology International, Vol 60, Iss 4, Pp 473-481 (2011)
Background: Bronchial asthma is a chronic inflammatory disease that has a severe impact on health worldwide. Methods: A survey of 10,771 patients with bronchial asthma in the Tama region, Tokyo was conducted for 5 years to examine treatment and quali
Externí odkaz:
https://doaj.org/article/319d90cce551450b82dbbd6d6033caef
Autor:
Shizuka Watanabe, Maho Suzukawa, Hiroyuki Tashimo, Nobuharu Ohshima, Isao Asari, Kazufumi Takada, Sahoko Imoto, Takahide Nagase, Ken Ohta
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 2, p179-187, 9p
Autor:
Miki Ikeda, Masahiro Kawashima, Meiko Shiina, Masashi Kitani, Maho Suzukawa, Nobuharu Ohshima
Publikováno v:
Internal Medicine. 61:755-759
The use of biologic agents has enabled control of severe asthma, but there is a risk that eosinophilic granulomatosis with polyangiitis (EGPA) may be masked in some cases. We herein report a 71-year-old man who was administered dupilumab for 2 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53d22fc479b97a0bee5a454317c7cdd2
https://doi.org/10.2169/internalmedicine.7990-21
https://doi.org/10.2169/internalmedicine.7990-21
Autor:
Masahiro Kawashima, Junko Suzuki, Atsuhisa Tamura, Katsuji Teruya, Nobuharu Ohshima, Ryota Sato, Ken Ohta, Akira Yamane, Isao Asari, Masahiro Shimada, Keita Takeda, Maho Suzukawa, Shunsuke Akashi, Hideaki Nagai, Eri Inoue, Shigeto Tohma
Publikováno v:
Journal of Infection and Chemotherapy. 27:617-624
Introduction The new-generation QuantiFERON (QFT)-TB Gold Plus (QFT-Plus) is expected to be useful because it includes a new peptide that is supposed to induce a CD8+ T cell response. There is a need for a new marker with sensitivity higher than that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0b2cf2b54f383c954401fb0a31680fb
https://doi.org/10.1016/j.jiac.2020.11.023
https://doi.org/10.1016/j.jiac.2020.11.023